/24-7PressRelease/ - MONROVIA, CA, June 20, 2008 - Laurence Flint, Associate Director of Clinical Research at Schering-Plough Research Institute will be speaking at GTCbio's Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA. Dr. Flint will present on practical approaches for pediatric trials.
Running modern pharmaceutical and biologic clinical trials is an increasingly demanding and costly undertaking, even under the best of circumstances. These challenges are even greater when done in a pediatric patient population, and present additional scientific, logistical and ethical difficulties to even the most experienced development teams. However, with recent legislative changes, and the needs of the medical community and the healthcare marketplace, Schering-Plough Research Institute as sponsors must now increase their research efforts in this vulnerable population, where quality efficacy and safety information is so very important to the effective care of children. Dr. Flint's presentation will address the major issues commonly encountered with trials in a pediatric population and look at practical solutions that sponsors can use when planning and conducting these types of studies. The issues being presented will include designing "family friendly" trials, addressing special ethical and logistical issues, way to encourage patient recruitment and retention, understanding fundamental differences within pediatric age groups, and maximizing a team approach to running pediatric drug development programs.
The Global Clinical Trial Operations conference brings together leaders, directors, vice presidents, heads, managers, supervisors, and CROs from all over the world to collaborate and discuss the latest developments in clinical trial operations and logistics and covers clinical trials in emerging markets, first-in-man clinical trials, pediatric clinical trials, material storage, distribution, site selection, patient recruitment and retention, technology in clinical trials and case studies of running global clinical trials.
For more information including a detailed agenda, exhibitor opportunities and registration information visit http://gtcbio.com/conferenceDetails.aspx?id=127.
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, infogtcbio@gtcbio.com
# # #
Read more Press Releases from Rania Hafez:- Johan Luthman, Global Head of Exploratory Medicine Neurology at MerckSerono to Give Plenary Keynote Address at 4th Modern Drug Discovery & Development Summit (Oct. 15-17, 2008 - San Diego, CA)
- Herbert Fritsche, Professor and Chief of Clinical Chemistry at MD Anderson Cancer Center to Give Keynote Presentation at GTCbio's Biomarker Discovery Europe Conference on October 2-3, 2008 in Dublin, Ireland
- Mike Romanos, Vice President of Discovery Technologies at GlaxoSmithKline to Give Keynote Presentation at GTCbio's Biomarker Discovery Europe Conference on October 2-3, 2008 in Dublin, Ireland
- Sharath Hegde, Vice President at Theravance to Give Featured Presentation at GTCbio's Bugs & Drugs Conference on September 22-23, 2008 in San Diego, CA
- Barry Eisenstein, SVP at Cubist Pharmaceuticals to Give Keynote Presentation at GTCbio's Bugs & Drugs Conference on September 22-23, 2008 in San Diego, CA
- VP of Alliance Management & Portfolio Planning at Genentech to Give Plenary Keynote Address at 4th Modern Drug Discovery & Development Summit (Oct. 15-17, 2008 - San Diego, CA)
- GTCBIO ANNOUNCES ITS ANNUAL CONFERENCE GLOBAL CLINICAL TRIAL OPERATIONS ON SEPTEMBER 25-26, 2008, SAN DIEGO, CA
- GTCBIO ANNOUNCES ITS BIOMARKER DISCOVERY EUROPE CONFERENCE ON OCTOBER 2-3, 2008 IN DUBLIN, IRELAND
- GTCBIO ANNOUNCES ITS 4th ANNUAL NEURODEGENERATIVE DISEASES DRUG DISCOVERY CONFERENCE ON OCTOBER 9-10, 2008 IN PHILADELPHIA, PA
- GTCBIO ANNOUNCES ITS INAUGURAL BUGS & DUGS CONFERENCE ON SEPTEMBER 22-23, 2008, SAN DIEGO, CA
